Through down-regulation of MMP2 and 9 paralleled by up-regulation of their inhibitors (TIMP2 and 3), Pug attenuated the migratory potential of human cervical and ovarian cancers [20,27]. This evidence concerns the gene TIMP2 and ovarian carcinoma.